These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38035050)

  • 1. The Faces of Financial Toxicity: A Qualitative Interview Study of Financial Toxicity in Advanced Cancer Patients in Phase I Oncology Trials.
    Williams C; Meyer L; Kawam O; Leventakos K; DeMartino ES
    Mayo Clin Proc Innov Qual Outcomes; 2023 Dec; 7(6):524-533. PubMed ID: 38035050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.
    Huey RW; George GC; Phillips P; White R; Fu S; Janku F; Karp DD; Naing A; Piha-Paul S; Subbiah V; Tsimberidou AM; Pant S; Yap TA; Rodon J; Meric-Bernstam F; Shih YT; Hong DS
    Oncologist; 2021 Jul; 26(7):588-596. PubMed ID: 33783054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention.
    Nipp RD; Lee H; Gorton E; Lichtenstein M; Kuchukhidze S; Park E; Chabner BA; Moy B
    Oncologist; 2019 Aug; 24(8):1048-1055. PubMed ID: 30988039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial toxicity among individuals with spina bifida and their families: A qualitative study and conceptual model.
    Aksenov LI; Fairchild RJ; Hobbs KT; Tejwani R; Wiener JS; Routh JC
    J Pediatr Urol; 2022 Jun; 18(3):290.e1-290.e8. PubMed ID: 35410804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer.
    Olson RE; Smith A; Good P; Dudley M; Gurgenci T; Hardy J
    Health Expect; 2023 Feb; 26(1):160-171. PubMed ID: 36335552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term and long-term financial toxicity from breast cancer treatment: a qualitative study.
    Lee S; Olvera RG; Shiu-Yee K; Rush LJ; Tarver WL; Blevins T; McAlearney AS; Andersen BL; Paskett ED; Carson WE; Chen JC; Obeng-Gyasi S
    Support Care Cancer; 2023 Dec; 32(1):24. PubMed ID: 38095729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.
    Nipp RD; Lee H; Powell E; Birrer NE; Poles E; Finkelstein D; Winkfield K; Percac-Lima S; Chabner B; Moy B
    Oncologist; 2016 Apr; 21(4):467-74. PubMed ID: 26975867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerating cancer clinical trial recruitment through a financial reimbursement program integrated with patient navigation: an interrupted time series analysis.
    Borno HT; Lin TK; Zhang S; Skafel A; Lalanne A; Dornsife D; Johnson R; Spicer D; Small EJ; Rhoads KF
    J Cancer Policy; 2021 Dec; 30():100305. PubMed ID: 35559801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial toxicity among older cancer survivors in China: a qualitative study of oncology providers' perceptions and practices.
    Liu L; Cao Y; Su M; Zhang J; Miao Y; Yao N
    Support Care Cancer; 2022 Nov; 30(11):9433-9440. PubMed ID: 35917024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: a systematic review of qualitative studies.
    Fitch MI; Sharp L; Hanly P; Longo CJ
    J Cancer Surviv; 2022 Apr; 16(2):314-328. PubMed ID: 33723742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on Access to Novel Therapeutics Through Clinical Trials Among Adolescents and Young Adults with Advanced Cancer: Implications for Patient-Centered Clinical Trials.
    Keim-Malpass J; Callahan LB; Lindley LC; Templeman CA; Mooney-Doyle K
    J Adolesc Young Adult Oncol; 2023 Feb; 12(1):53-58. PubMed ID: 35235445
    [No Abstract]   [Full Text] [Related]  

  • 12. Availability and Accessibility of Cancer Care Delivery Approaches to Reduce Financial Toxicity of Rural and Urban Cancer Patients in Kentucky.
    Edward J; Bowling W; Chitwood H; Vanderpool R
    J Oncol Navig Surviv; 2022 May; 13(5):156-164. PubMed ID: 36698508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparities in phase 1 cancer clinical trial enrollment.
    Perni S; Moy B; Nipp RD
    Cancer; 2021 Dec; 127(23):4464-4469. PubMed ID: 34379799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How cancer programs identify and address the financial burdens of rural cancer patients.
    Petermann V; Zahnd WE; Vanderpool RC; Eberth JM; Rohweder C; Teal R; Vu M; Stradtman L; Frost E; Trapl E; Koopman Gonzalez S; Vu T; Ko LK; Cole A; Farris PE; Shannon J; Lee J; Askelson N; Seegmiller L; White A; Edward J; Davis M; Wheeler SB
    Support Care Cancer; 2022 Mar; 30(3):2047-2058. PubMed ID: 34655327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Financial Toxicities of Patients with Locally Advanced Head and Neck Malignancies, Being Treated in a Private Sector Hospital in North India: A Thematic Analysis.
    Joshi S; Joshi U; Bahl A; Arya D; Anand AK; Arora RS
    Indian J Palliat Care; 2021; 27(1):118-125. PubMed ID: 34035629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies.
    Cohen JW; Akshintala S; Kane E; Gnanapragasam H; Widemann BC; Steinberg SM; Shah NN
    Oncologist; 2020 Jun; 25(6):532-540. PubMed ID: 31943534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial Toxicity and Equitable Access to Clinical Trials.
    Chino F; Zafar SY
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():11-18. PubMed ID: 31099681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates.
    Andrews C; Childers TC; Wiseman KD; Lawhon V; Ingram S; Smith ML; Wolff AC; Wagner L; Rocque GB
    BMC Cancer; 2022 Feb; 22(1):141. PubMed ID: 35120494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences of a Multiethnic Cohort of Patients Enrolled in a Financial Reimbursement Program for Cancer Clinical Trials.
    Medina SP; Zhang S; Nieves E; Dornsife DL; Johnson R; Spicer D; Borno HT
    JCO Oncol Pract; 2023 May; 19(5):e801-e810. PubMed ID: 36800640
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.